Two recent pleiotropic approaches evaluating the effects of genetic variants associated with cardiovascular and metabolic risk factors on cognitive impairment conditions have identified that circulating lipid parameters in subjects with cognitive impairment are associated with the APOE-TOMM40-APOC1-PVRL2 loci on chromosome 19 [15,16]. This evidence concerns the gene APOE and Cognitive impairment.